*CLSA bullish on pharma but downgrades Biocon, Ranbaxy
*Betting on largecap IT, vice industry, pharma: Axis Cap
*’Risky’ firms may need Rs 1 trillion refinancing by Mar ’15: India Ratings
*India faces ‘slow recovery year’ in 2014: Citigroup
*Worst of inflation over; don’t see rate cuts soon: ICICI Bank
*Developed mkt performance may hit emerging mkt flows: MSCI
*Verizon to launch new Nokia ‘Icon’ handset
*Apple, Samsung agree to mediation in US patent fight
*Rupee to stabilise this year after 2013 slide: Reuters poll
*Mumbai’s Tulip Star Hotel property finds no takers: Sources
*Container Corp eyes 10% revenue growth by FY14-end
*Loan book may grow 8-9% post rise in lending limit: Manappuram
*Hindustan Motors plans to demerge Chennai facility facing hurdles
*Birla Corp to take legal recourse against mine deallocation
*Compat to hear appeal against Jet-Etihad deal after 3 weeks
*Edelweiss set to raise up to Rs 500 cr via bonds
*Suven gets 3 product patents in Australia, Sri Lanka, South Korea
*Irda shifts focus to distribution
Tata-Singapore Airlines JV orders Airbus A320s: sources
*Financial Technologies extends rally, stock surges over 75% in one week
*Ranbaxy enters into licensing pact with EPIRUS Switzerland
*Tata opens fourth international nodal office in Singapore
*Domestic car sales down 4.5% in Dec: SIAM
*Rakesh Jhunjhunwala cuts stake in Lupin
*RIL starts gas production from new well in KG basin
*Fund raising via debt placement drops 11% to Rs 3 lakh cr
*FTIL may seek more time to reduce MCX-SX stake
*Coal India appeals against CCI’s Rs 1,773 crore penalty order
*Coal India may miss production target for FY14: CMD
*Government to seek foreign investment in giant, creaking rail network
*Govt exempts shipping vessel sharing pacts from CCI purview
*Sensex closes flat ahead of Infosys Q3 numbers; banks fall
*Oil Minister: EGoM defers decision on IOC divestment
*Govt’s debt structure supports current ratings: Moody’s
